191
Views
6
CrossRef citations to date
0
Altmetric
Research Article

HIV-associated lung cancer: Survival in an unselected cohort

, , , , , , , , , , , , , & show all
Pages 766-772 | Received 24 Feb 2013, Accepted 13 May 2013, Published online: 23 Jul 2013

References

  • Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 2006;24:1383–8.
  • Cadranel J, Garfield D, Lavole A, Wislez M, Milleron B, Mayaud C. Lung cancer in HIV infected patients: facts, questions and challenges. Thorax 2006;61:1000–8.
  • Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009;100:840–7.
  • Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425–32.
  • Frisch M, Biggar RJ, Engels EA, Goedert J. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285:1736–45.
  • Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, Brown ST, et al. HIV as an independent risk factor for incident lung cancer. AIDS 2012;26:1017–25.
  • Hakimian R, Fang H, Thomas L, Edelman MJ. Lung cancer in HIV-infected patients in the era of HAART. J Thorac Oncol 2007;2:268–72.
  • Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003;21:3447–53.
  • Bower M, Powles T, Nelson M, Shah P, Cox S, Mandelia S, Gazzard B. HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 2003;17:371–5.
  • Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011; 103:753–62.
  • Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009;10:1152–9.
  • Kirk GD, Merlo C, O’Driscoll P, Mehta SH, Galai N, Vlahov D, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007;45:103–10.
  • Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA. Elevated risk of lung cancer among people with AIDS. AIDS 2007;21:207–13.
  • Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med 2006;166:1359–67.
  • Morlat P, Roussillon C, Hénard S, Rosenthal E, Oksenhendler E, Aouba A, et al. Evolution of the causes of death among HIV+ patients between 2000 and 2010: results of the French National Survey “ANRS EN20 Mortalité 2010”. Abstract 1130. Program and abstracts of the 19th Conference on Retroviruses and Opportunistic Infections 2012, Seattle, USA.
  • Tirelli U, Spina M, Sandri S, Serraino D, Gobitti C, Fasan M, et al. Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer 2000;88:563–9.
  • Spano JP, Massiani MA, Bentata M, Rixe O, Friard S, Bossi P, et al. Lung cancer in patients with HIV infection and review of the literature. Med Oncol 2004;21:109–15.
  • Powles T, Thirwell C, Newsom-Davis T, Nelson M, Shah P, Cox S, et al. Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?Br J Cancer 2003;89:457–9.
  • Brock MV, Hooker CM, Engels EA, Moore RD, Gillison ML, Alberg AJ, et al. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr 2006;43:47–55.
  • Lavolé A, Chouaïd C, Baudrin L, Wislez M, Raguin G, Pialoux G, et al. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer 2009;65:345–50.
  • D’Jaen GA, Pantanowitz L, Bower M, Buskin S, Neil N, Greco EM, et al. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer 2010;11:396–404.
  • Makinson A, Tenon JC, Eymard-Duvernay S, Pujol JL, Allavena C, Cuzin L, et al. Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study. J Thorac Oncol 2011;6:1022–9.
  • Biggar RJ, Engels EA, Ly S, Kahn A, Schymura MJ, Sackoff J, et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005;39: 293–9.
  • Rengan R, Mitra N, Liao K, Armstrong K, Vachani A. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol 2012;13:1203–9.
  • Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, et al. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS 2012;26: 2223–31.
  • Navarro G, Nogueras MM, Segura F, Casabona J, Miro JM, Murillas J, et al. HIV-1 infected patients older than 50 years. PISCIS cohort study. J Infection 2010;57:64–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.